UNITY Biotechnology Inc at Goldman Sachs Global Healthcare Conference Transcript
Great. So good morning, everybody, and welcome to Goldman Sachs' 40th Annual Healthcare Conference. My name is Ross Weinreb. I'm one of the biotech technology associates here, and it's my pleasure to introduce Keith Leonard, CEO and Chairman of UNITY Biotechnology.
Questions & Answers
So Keith, it's been about a year since your IPO. Can you walk us through some of the pipeline progress you guys have made thus far? And any incremental updates that we should be looking forward to over the next 6 months?
Sure. So as many of you may know, UNITY is a company focused on extending health span. We do that by attacking specific diseases of aging, where our aim is to slow, halt or reverse those diseases of aging. The progress on the pipeline in that mission in the last year,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |